Consumer products giant Reckitt announced Thursday that it surpassed fourth-quarter sales projections, powered by exceptional performance in developing nations, while projecting 4% to 5% growth for its primary business segments through 2026.
The British company, similar to industry competitors like Nestle and Unilever, has been restructuring its brand portfolio to concentrate on higher-profit, faster-growing products. Reckitt completed the sale of its Essential Home division to private equity company Advent International for $4.8 billion on December 31, while maintaining a 30% ownership interest.
The manufacturer of well-known brands including Durex contraceptives and Lysol disinfectants announced comparable net revenue increases of 5.4% for the three months ending December 31, surpassing analyst predictions of 4.7% growth according to company-gathered forecasts.
Throughout the full year, developing market sales jumped 14.6%, creating a stark contrast with European markets, which declined 1.4%.
Developing nations, representing approximately 42% of Reckitt’s primary revenue streams, have now achieved double-digit sales increases for 10 straight quarters, according to Barclays financial analysts.
“(Emerging Markets) is doing the heavy lifting for the group and provides a reliable growth engine at a time when developed markets category growth is sluggish,” the analysts said in a note.
Company executives indicated they anticipate continued difficulties in European markets and cautioned that their seasonal over-the-counter medication business may face headwinds in early 2026 due to a milder cold and flu season than typical.
